– Mitochondrial Peptide for Metabolic Research
(MOTS-c) | 40mg Vial | Ultra-Pure | ≥99% Peptide-Grade Purity
🔬 High-Purity Research Peptide – Synthesized for reproducible laboratory use
🧪 Verified for Quality – HPLC Tested, COA Provided on request, Third-Party Tested
📚 Backed by Scientific Literature – Studies highlight its role in energy homeostasis
Chemical Information
• Synonyms: Mitochondrial-Derived Peptide, Mitochondrial Open Reading Frame of the 12S rRNA-c
• CAS Number: Not officially assigned
• Molecular Formula: C₉₀H₁₄₀N₂₈O₂₀S₂
• Form: Lyophilized powder, 40mg per vial
• Purity: ≥99% (Peptide-grade)
• Storage: Store at 2–8°C, protected from light
Product Assurance
✅ HPLC Verified – Ensuring ≥99% purity
✅ COA Provided – On Request
✅ Dispatched in the UK
✅ Third-Party Testing Available
✅ Express Delivery – Ensuring Potency & Integrity
⚠️ For Research Use Only
MOTS-C is supplied strictly for scientific research purposes. Not approved for human or veterinary use.
Not Medical Products: None of the products listed our website are medical products, nor should they be marketed or used as such.
Compliance and Responsibility: The buyer is responsible for ensuring compliance with all relevant laws and regulations. Maxx Labs holds no liability for misuse of products or any adverse outcomes.
Handle with appropriate lab safety procedures.
⚠️ For Research Use Only – Not for Human Consumption
This product is intended strictly for laboratory research purposes and is not approved for human or veterinary use, therapeutic application, or diagnostic procedures. All handling must be performed by trained professionals in compliance with appropriate laboratory safety protocols and applicable regulations.
18+ Notice: This material is not for sale to individuals under the age of 18. By purchasing, you confirm that you are a qualified individual or acting on behalf of a qualified institution, and that the compound will be used exclusively for legitimate scientific investigation.
We acknowledge that in certain regions—particularly in countries outside of the United Kingdom, where manufacturing oversight and regulatory enforcement may be less stringent—there are isolated cases of individuals attempting to self-administer research compounds. We strongly discourage and explicitly warn against any such misuse. The self-experimentation of unapproved substances carries significant, unquantifiable risks and is both medically irresponsible and ethically unsound. Without proper analytical validation, GMP-level controls, and clinical context, the safety, quality, and pharmacological reliability of these materials cannot be assured.
All compounds must be handled in secure, controlled environments by competent personnel. Any deviation from these principles is contrary to responsible research practice and breaches both our terms of sale and the intended scientific use of these products.
